Canopy Growth Reports Fourth Quarter and Fiscal Year 2026 Financial Results; Delivers Q4 FY2026 Net Revenue Growth of 27% in Canada Medical and 68% in International Markets Cannabis

Key Takeaway: Canopy Growth has reported its financial results for the fourth quarter and fiscal year 2026, highlighting a net revenue growth of 27% in Canada’s medical cannabis sector and 68% growth in international markets. The report reflects the company's ongoing efforts to expand its market presence and improve financial performance. Further details on operational strategies and future outlook were not disclosed.